Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathology
Open Access
- 9 August 2010
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 207 (9) , 1907-1921
- https://doi.org/10.1084/jem.20092749
Abstract
Natural killer (NK) cells of the innate immune system can profoundly impact the development of adaptive immune responses. Inflammatory and autoimmune responses in anatomical locations such as the central nervous system (CNS) differ substantially from those found in peripheral organs. We show in a mouse model of multiple sclerosis that NK cell enrichment results in disease amelioration, whereas selective blockade of NK cell homing to the CNS results in disease exacerbation. Importantly, the effects of NK cells on CNS pathology were dependent on the activity of CNS-resident, but not peripheral, NK cells. This activity of CNS-resident NK cells involved interactions with microglia and suppression of myelin-reactive Th17 cells. Our studies suggest an organ-specific activity of NK cells on the magnitude of CNS inflammation, providing potential new targets for therapeutic intervention.Keywords
This publication has 63 references indexed in Scilit:
- Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab′) 2Proceedings of the National Academy of Sciences, 2010
- How Punctual Ablation of Regulatory T Cells Unleashes an Autoimmune Lesion within the Pancreatic IsletsImmunity, 2009
- Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple SclerosisArchives of Neurology, 2009
- Regulation of CD8+regulatory T cells: Interruption of the NKG2A–Qa-1 interaction allows robust suppressive activity and resolution of autoimmune diseaseProceedings of the National Academy of Sciences, 2008
- IL-21 and TGF-β are required for differentiation of human TH17 cellsNature, 2008
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory PathwayImmunity, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Regulatory CD56brightnatural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosisProceedings of the National Academy of Sciences, 2006
- Immune functions encoded by the natural killer gene complexNature Reviews Immunology, 2003